EE200100020A - NAB1 ja NAB2 farmatseutiline kasutamine - Google Patents

NAB1 ja NAB2 farmatseutiline kasutamine

Info

Publication number
EE200100020A
EE200100020A EEP200100020A EEP200100020A EE200100020A EE 200100020 A EE200100020 A EE 200100020A EE P200100020 A EEP200100020 A EE P200100020A EE P200100020 A EEP200100020 A EE P200100020A EE 200100020 A EE200100020 A EE 200100020A
Authority
EE
Estonia
Prior art keywords
nab1
nab2
pharmaceutical use
pharmaceutical
Prior art date
Application number
EEP200100020A
Other languages
English (en)
Inventor
Braddock Martin
Jeffrey Campbell Callum
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en
Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200100020A publication Critical patent/EE200100020A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200100020A 1998-07-11 1999-07-09 NAB1 ja NAB2 farmatseutiline kasutamine EE200100020A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9814989.1A GB9814989D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method
PCT/GB1999/002199 WO2000003014A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2

Publications (1)

Publication Number Publication Date
EE200100020A true EE200100020A (et) 2002-06-17

Family

ID=26314007

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100020A EE200100020A (et) 1998-07-11 1999-07-09 NAB1 ja NAB2 farmatseutiline kasutamine

Country Status (22)

Country Link
EP (1) EP1097200A1 (et)
JP (1) JP2002520020A (et)
KR (1) KR20010071832A (et)
CN (1) CN1317045A (et)
AP (1) AP2001002038A0 (et)
AU (1) AU763713B2 (et)
BR (1) BR9912018A (et)
CA (1) CA2336805A1 (et)
EA (1) EA200100028A1 (et)
EE (1) EE200100020A (et)
HR (1) HRP20010025A2 (et)
HU (1) HUP0102835A3 (et)
ID (1) ID27742A (et)
IL (1) IL140533A0 (et)
IS (1) IS5788A (et)
NO (1) NO20010166L (et)
NZ (1) NZ509174A (et)
PL (1) PL345507A1 (et)
SK (1) SK382001A3 (et)
TR (1) TR200100622T2 (et)
WO (1) WO2000003014A1 (et)
YU (1) YU1901A (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
US6753321B2 (en) 2000-09-15 2004-06-22 Genvec, Inc. Method of modulating neovascularization
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection

Also Published As

Publication number Publication date
NO20010166L (no) 2001-03-06
AU763713B2 (en) 2003-07-31
CN1317045A (zh) 2001-10-10
BR9912018A (pt) 2006-01-31
SK382001A3 (en) 2001-09-11
TR200100622T2 (tr) 2001-10-22
HUP0102835A2 (hu) 2001-11-28
NO20010166D0 (no) 2001-01-10
NZ509174A (en) 2003-08-29
PL345507A1 (en) 2001-12-17
KR20010071832A (ko) 2001-07-31
AU4791499A (en) 2000-02-01
HRP20010025A2 (en) 2001-12-31
IS5788A (is) 2000-12-22
WO2000003014A1 (en) 2000-01-20
YU1901A (sh) 2005-06-10
HUP0102835A3 (en) 2003-09-29
EA200100028A1 (ru) 2001-08-27
ID27742A (id) 2001-04-26
EP1097200A1 (en) 2001-05-09
AP2001002038A0 (en) 2001-03-31
IL140533A0 (en) 2002-02-10
JP2002520020A (ja) 2002-07-09
CA2336805A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
EE04144B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
BR9500784A (pt) Composto e formulação farmacêutica
PT1066027E (pt) Composicao farmaceutica de topiramato
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
DE69925262D1 (de) Pharmazeutika zur bildgebung der angiogenischen krankheiten
EE200100258A (et) Antraniilhappe amiidid ja nende kasutamine ravimitena
FI972292A0 (fi) Administrering av diabetes
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
IS5425A (is) Læknislyf
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
PT934057E (pt) Formulacoes medicinais de aerossois com formoterol
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
FI965204A0 (fi) Bromelaiinin lääkekäyttö
DE69900823D1 (de) Injizierbare arzneizubereitung bestehend aus paracetamol
ATA191697A (de) Arzneimittel zur förderung der wundheilung
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
FI964619A (fi) Epilepsialääkkeiden iholle annostelu
PT1194038E (pt) Composicao de quebra do repouso e sua utilizacao
PT1017388E (pt) Composicao farmaceutica contendo ibuprofeno e domperidona para o tratamento de enxaqueca
EE04870B1 (et) Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid
EE200100020A (et) NAB1 ja NAB2 farmatseutiline kasutamine
EE200100084A (et) NOS inhibiitorite uued farmatseutilised kasutusvoimalused
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
BR9703132A (pt) Temporizador medicinal